Skip to main content

The Wistar Institute

|

The Art and Science of Dr. Livio Azzoni

Dr. Livio Azzoni racks up 20+ miles a week running to and from work at The Wistar Institute. This senior staff scientist in the laboratory of Dr. Luis Montaner took up running 13 years ago because he was, “Growing, but in the wrong direction. [I] …
|

Noam Auslander, Ph.D.

Assistant Professor, Molecular and Cellular Oncogenesis Program, Ellen and Ronald Caplan Cancer Center
|

Dario C. Altieri, M.D.

President and Chief Executive Officer Director, Ellen and Ronald Caplan Cancer Center Robert and Penny Fox Distinguished Professor, Genome Regulation and Cell Signaling Program
|

Wistar Scientists Honored, Speak at AIDS Education Month Event

Pride Month in Philadelphia, PA, is celebrated alongside another worthy cause: AIDS Education Month, an event series organized by the nonprofit Philadelphia FIGHT to raise awareness of those living with AIDS, AIDS treatments & healthcare and A…
|

Wistar’s Biomedical Technical Training Program Featured on Fox 29 Good Day Philadelphia

The Wistar Institute’s Biomedical Technical Training (BTT) Program was recently featured on Fox 29’s Good Day Philadelphia. Dr. Kristy Shuda McGuire, Dean of Biomedical Studies, and 2022 Program graduate Tylier Driscoll, discussed the history of t…
|

The Wistar Institute Appoints Former City Solicitor Sozi Tulante to Its Board of Trustees

PHILADELPHIA — (May 26, 2023) — The Wistar Institute, a global leader in biomedical research in cancer, immunology and infectious disease, is pleased to welcome Sozi Tulante to its Board of Trustees. He is currently General Counsel of Form Energy,…
|

Wistar Scientists Successfully Engineer a Goldilocks Construct: Therapeutic Antibody Could Be a Future Medicine to Improve Outcomes for Melanoma

In recent years, multimodal therapies have emerged as a route to treat cancer by delivering different types of treatments together to improve effectiveness. However, the more modalities there are, the more complex the production and effects of the…
|

Balancing Act: It’s a Fine Line Between Inflammation and Immunity When Viruses are Involved

Dr. Mohamed Abdel-Mohsen’s Pioneering Research on Siglecs Spotlights Their Role Helping the Immune System Recognize Viral Infections, and as Promising Future Therapy Dr. Mohamed Abdel-Mohsen and his virology lab at The Wistar Institute review…
|

Coordination/Synthetic Chemist Returns to Cameroon Ready to Train Next Generation of African Scientists on Wistar’s World-Class Analytic Chemistry Techniques

“Our hope is to build a center with the same reflection of Wistar in science and administration.” In three short months as a Visiting Scholar with The Wistar Institute in Philadelphia, Donatus Bekindaka Eni, BSc., MSc., Ph.D., a lecturer from the …
|

Notes From the Field: Seeing Research in Action

More than 1,000 supporters gathered in Fairmont Park for PanCAN PurpleStride Philadelphia 2023 to support the Pancreatic Cancer Action Network (PanCAN). Wistar’s Dr. Rahul Shinde is a PanCAN research grant recipient, and our lab was honored to att…